TECXTectonic Therapeutic, Inc.
$23.39+52% 1Y
$23.39
$16.0252 weeks$37.82
Price
+52%1YEnd-of-day closes, not the intraday tick.
RyuScore
Weak, higher than 23% of companiesThe five questions
2 of 5 availableOnly two of the five can be answered for TECX today. The rest need figures this filer has not published. The tabs above still show whatever data does exist.
- Is the business good?not enough filed
- Is it safe?Watch
- Is the price fair?not enough filed
- Is it growing?not enough filed
- What is the market doing?Mixed
P/En/a
Market value$428.0M
1 year+52%
5 years-65%
Charts
As reported to the SEC, without any scoring.
The next results filing is expected around Nov 5, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Sep 29, 2026On September 29, 2026, Tectonic Therapeutic, Inc. issued a press release titled “Tectonic Therapeutic Announces Favorable Phase 1 Safety, Tolerability and PK Results for TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)”Other event · Form 8-K
- Aug 6, 2026Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights.Earnings release · press release
- Jun 10, 2026On June 8, 2026, Tectonic Therapeutic, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). As of the close of business on April 13, 2026, the record date for the Annual Meeting, 18,848,500 shares of common stock were outstanding and entitled to vote at the Annual Meeting.Shareholder vote results · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.